Skip to main content
. 2015 Nov 24;9:105–112. doi: 10.4137/CMO.S32812

Table 6.

RR for ORR of arm A over arm B.

CHARACTERISTICS ARM A (45) ARM B (38) P-VALUE
NUMBER % NUMBER %
Age (At time of metastases)
18–<40 2 4 3 7 0.09
40–<51 9 20 10 26 0.08
51–<65 16 36 14 37 0.15
65–70 18 40 11 30 0.06
Age (median) 53 50 0.9
Body mass index (BMI)
<25 0 0 22 58
25–29.9 0 0 16 42
≥30% 45 100 0 0
BMI (median) 33 21 0.04
Performance status (ECOG)
0 22 49 24 58 0.09
1 15 34 10 27 0.06
2 8 17 6 15 0.09
Performance status (median) 0 0 0.1
Pathological classification
Ductal 41 91 32 84 0.06
Lobular 4 9 6 16 0.08
Pathological grade
1 0 0 0 0
2 19 42 18 47 0.09
3 26 58 20 53 0.07
Grade (median) 3 3 0.1
Initial stage (pathological)
I–II 15 33 10 27 0.06
III 14 31 13 34 0.09
IV 16 36 15 39 0.08
Number of positive lymph node
0 2 4 2 5 0.1
1–3 13 29 8 21 0.07
4–9 14 31 10 26 0.08
>9 3 7 4 11 0.06
Unknown 13 29 14 37 0.06
Lymph node number (median) 5 4.5 0.1
Metastases site
Lung 15 33 12 32 0.09
Liver 20 45 16 42 0.07
Both 5 11 3 8 0.08
Bone 1 2 2 5 0.06
Bone and visceral 4 9 5 13 0.06
Receptor status: Her 2 neu
Positive 16 35 13 34 0.1
Negative 29 65 25 66 0.1
Invasion
Lymphatic 14 31 18 47 0.06
Vascular/Perineural 10 22 12 31 0.06